Equillium Inc (EQ)
1.67
+0.11
(+7.05%)
USD |
NASDAQ |
May 03, 16:00
1.69
+0.02
(+1.20%)
After-Hours: 20:00
Equillium Revenue (TTM): 36.08M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 36.08M |
Date | Value |
---|---|
September 30, 2023 | 42.63M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
36.08M
Minimum
Dec 2023
42.63M
Maximum
Sep 2023
39.36M
Average
39.36M
Median
Revenue (TTM) Benchmarks
Janux Therapeutics Inc | 8.083M |
Mersana Therapeutics Inc | 36.86M |
Vera Therapeutics Inc | -- |
Jasper Therapeutics Inc | -- |
PepGen Inc | -- |